Bright Minds Biosciences (DRUG) Depreciation & Amortization (CF) (2022 - 2026)
Bright Minds Biosciences' (DRUG) quarterly Depreciation & Amortization (CF) came in at $14439.0 in Q1 2026, down 7.84% YoY from $15667.4 in Q1 2025, and up 1.75% on a QoQ basis from $14190.4 in Q4 2025.
Bright Minds Biosciences (DRUG) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends
Bright Minds Biosciences (DRUG) has 5 years of Depreciation & Amortization (CF) data on file, last reported at $14439.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 40.52 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Bright Minds Biosciences | 733.05 Mn | 733.05 Mn | - | 14,439.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,439.00 |
| Mar 31, 2026 | 14,439.00 |
| Dec 31, 2025 | 14,190.42 |
| Dec 31, 2025 | 14,190.42 |
| Jun 30, 2025 | 11,435.53 |
| Jun 30, 2025 | 11,435.53 |
| Mar 31, 2025 | 15,667.38 |
| Mar 31, 2025 | 15,667.38 |
| Dec 31, 2024 | 15,414.38 |
| Dec 31, 2024 | 15,414.38 |
| Jun 30, 2024 | -21,851.60 |
| Jun 30, 2024 | -21,851.60 |
| Mar 31, 2024 | 13,441.15 |
| Mar 31, 2024 | 13,441.15 |
| Dec 31, 2023 | 13,304.64 |
| Dec 31, 2023 | 13,304.64 |
| Jun 30, 2023 | 13,484.27 |
| Jun 30, 2023 | 13,484.27 |
| Mar 31, 2023 | 13,398.12 |
| Mar 31, 2023 | 13,398.12 |